4.5 Review

Drug Re-purposing Approach and Potential Therapeutic Strategies to Treat COVID-19

Journal

MINI-REVIEWS IN MEDICINAL CHEMISTRY
Volume 21, Issue 6, Pages 704-723

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557520666201113105940

Keywords

SARS-Cov-2; COVID-19; betacoronavirus; epidemiological; acute respiratory syndrome; FDA

Funding

  1. DST-SERB, New Delhi, India [SB/FT/CS-079/2014]

Ask authors/readers for more resources

This review summarizes the current therapeutic approaches for COVID-19, including drug synthesis and treatment strategies, aiming to inspire the scientific community to propose more effective treatment methods.
The current pandemic of COVID-19 caused by SARS-Cov-2 has posed a severe threat to the whole world with its highly infectious, progressive nature with up to 10% mortality rates. The severity of the situation faced by the whole world and the lack of efficient therapeutics to treat this viral disease have led the WHO to depend on the drug-repurposing approach to tackle this major global health problem. This review aims at highlighting the various synthetic approaches employed for the synthesis of these FDA approved drugs that have been presently used for COVID-19 treatment. Additionally, a brief overview of several therapeutic strategies is also presented. This review will encourage the scientific community across the globe to come up with better and efficient synthetic protocols and also novel chemical entities along with this core with more potent activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available